Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chemocentryx Inc
(NQ:
CCXI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 19, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Chemocentryx Inc
< Previous
1
2
3
4
5
6
Next >
Analyst Ratings For ChemoCentryx
July 07, 2021
Analysts have provided the following ratings for ChemoCentryx (NASDAQ:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021
July 07, 2021
Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
July 07, 2021
Keybanc cut Alibaba Group Holding Limited (NYSE: BABA) price target from $275 to $270. Alibaba shares rose 0.5% to $212.60 in pre-market trading. Needham boosted SMART Global...
Via
Benzinga
Why This ChemoCentryx Analyst Is Bullish
July 06, 2021
H.C. Wainwright analysts remain bullish on ChemoCentryx, Inc. (NASDAQ:
Via
Benzinga
ChemoCentryx Stock Is Approaching A Key Level
July 06, 2021
ChemoCentryx Inc. (NASDAQ: CCXI) shares traded higher Tuesday after the company announced it filed an amendment to its New Drug Application for avacopan for the treatment of anti-...
Via
Benzinga
ChemoCentryx Stock Jumps On Amendment In Avacopan Application, New Goal Date Of October 7
July 06, 2021
Following consultations with the FDA, ChemoCentryx Inc (NASDAQ: CCXI) filed an amendment to its marketing application seeking approval for avacopan to treat...
Via
Benzinga
Exposures
Product Safety
Biotech Losers In 2021 That Could Bounce Big In The Second Half
July 03, 2021
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to...
Via
Talk Markets
Biotech Losers In 2021 That Could Bounce Big In The Second Half
July 03, 2021
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off...
Via
Benzinga
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
July 03, 2021
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...
Via
Benzinga
Exposures
Product Safety
Is It Too Late to Buy ChemoCentryx Stock?
July 02, 2021
This biotech is traveling in uncharted waters.
Via
The Motley Fool
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
July 01, 2021
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...
Via
Benzinga
Is ChemoCentryx a Buy?
June 23, 2021
Next month is sure to be a big one for the company, with the FDA slated to make a decision on its most advanced drug, avacopan.
Via
The Motley Fool
Exposures
Product Safety
8 Health Care Stocks Showing Unusual Options Activity In Today's Session
June 11, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...
Via
Benzinga
CCXI Stock: 12 Things to Know About ChemoCentryx as Shares Surge Today
June 11, 2021
ChemoCentryx (CCXI) stock is on the rise Friday as investors anticipate one of its treatments getting approval from the FDA.
Via
InvestorPlace
28 Stocks Moving in Friday's Pre-Market Session
June 11, 2021
Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50...
Via
Benzinga
Why ChemoCentryx Stock Plunged 79% in May
June 04, 2021
When everything is riding on a single outcome, speed bumps can send a stock careening.
Via
The Motley Fool
The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing
May 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Exposures
COVID-19
Product Safety
40 Stocks Moving In Monday's Mid-Day Session
May 10, 2021
Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-average news. Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 35% to $2.97. Cue...
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop
May 07, 2021
Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks Reverse Course, Investors Look at Flip Side of Economic Data
May 07, 2021
While a lackluster April jobs report initially sunk stocks this morning, the indexes are bouncing back as investors speculate that the disappointing data could mean the continuation of easy policies...
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
70 Biggest Movers From Friday
May 10, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 07, 2021
Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why ChemoCentryx Stock Is Cratering Again Today
May 07, 2021
Investors aren't optimistic after an FDA advisory committee vote for avacopan.
Via
The Motley Fool
Exposures
Product Safety
Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide
May 07, 2021
Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why ChemoCentryx Shares Are Plunging Today
May 07, 2021
ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval on its Avacopan in ANCA-Associated...
Via
Benzinga
Exposures
Product Safety
Mid-Morning Market Update: Markets Open Higher; US Adds Only 266,000 Jobs In April
May 07, 2021
Following the market opening Friday, the Dow traded up 0.40% to 34,686.06 while the NASDAQ rose 1.16% to 13,790.95. The S&P also rose, gaining 0.69% to 4,230.68. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
56 Stocks Moving In Friday's Mid-Day Session
May 07, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....
Via
Benzinga
Analysts React To FDA AdCom Vote On ChemoCentryx's Avacopan, Stock Plunges
May 07, 2021
Yesterday, the FDA’s Arthritis Advisory Committee panelists went through cloudy data while complaining about the design of the Phase 3 trial for ChemoCentryx Inc...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.